
Similar Posts

Parkinson’s disease: ‘You can have a career after diagnosis’
A spokesperson for NHS England said: “While local NHS trusts are each responsible for their own medicines policy, NHS England has commissioned a range of support, information and resources for organisations on this issue, which have been used by hundreds of health professionals – we will continue to encourage their use so patients in hospital…

Balancing Act: Healthy Habits for Busy Professionals
In today’s fast-paced world, balancing work and personal life is more challenging than ever, especially for busy professionals. The demands of a high-pressure job can often lead to neglecting personal health and well-being. However, adopting healthy habits is crucial for maintaining energy, productivity, and overall life satisfaction. Here are practical tips for busy professionals to…

What we know about the Covid variant EG.5 dubbed ‘Eris’
The World Health Organisation declared the variant of interest, with cases reported in 51 countries.

Microplastics found in overwhelming majority of American meat, water, plants: study
A new study has found that the overwhelming majority of protein foods such as meat and fish are contaminated with microplastics. The comprehensive study, conducted by researchers at the nonprofit Ocean Conservancy, found that approximately 88% of protein samples tested contained microplastic particles. “Highly processed products contained the most microplastics per gram,” the study said…

Eli Lilly launches website to help patients get weight loss drugs
Drugmaker Eli Lilly announced on Thursday a new website that will allow patients to get a weight loss drug prescription through a telehealth provider — a move, the company says, that will improve access to the extremely popular and effective drugs, including its recently approved drug, Zepbound. The new website, called LillyDirect, joins a growing list of platforms like Weight…

J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Monday said it will pay $2 billion in cash to acquire Ambrx Biopharma, a drugmaker specializing in one of the hottest areas of cancer treatment….